Standard BioTools saw the highest growth of 1.49% in patent filings and 1.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.49% and grants by 1.49%. GlobalData’s DataBook provides a comprehensive analysis of Standard BioTools’s patent filings and grants. Buy the databook here.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Standard BioTools has been focused on protecting inventions in United States(US) with seven publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 17% filings and 62% grants. The World Intellectual Property Organization(WIPO), European Patent Office(EPO), United States(US), and Israel(IL) patent Office are among the top ten patent offices where Standard BioTools is filings its patents. Among the top granted patent authorities, Standard BioTools has 62% of its grants in United States(US), 25% in Japan(JP) and 12% in Israel(IL).

Standard BioTools stands in second position with respect to its patent publications among its competitors.

See Also:

Patents related to healthtech and machine learning lead Standard BioTools's portfolio

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Standard BioTools has the highest number of patents in healthtech followed by, machine learning and electronic medical record (emr) systems. For healthtech, nearly 33% of patents were filed and no patents were granted in Q2 2024.

Autonomous driving related patents lead Standard BioTools portfolio followed by healthcare it, and medical imaging information systems

Standard BioTools has highest number of patents in autonomous driving followed by healthcare it, medical imaging information systems, femtosecond laser, and machine learning.

For comprehensive analysis of Standard BioTools's filings and grants, buy the databook here.